These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24052436)

  • 1. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.
    Zhang Y; Wang Y; Wu J; Li LJ
    Tumour Biol; 2013 Aug; 34(4):2321-7. PubMed ID: 23681796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
    Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
    Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
    Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
    Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
    Tian Z; Li YL; Liu JG
    Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
    Mao D; Zhang Y; Lu H; Fu X
    Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
    J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.